TwinKnowledge | $3,700,000 | (Apr 3, 2025)
experial | $2,198,930 | (Apr 3, 2025)
Certified by Founder
Lodge
Koneksa
start up
United States
- New York
- 08/02/2022
- Series C
- $45,000,000
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.
- Industry Pharmaceutical Manufacturing
- Website http://www.koneksahealth.com/
- LinkedIn https://www.linkedin.com/company/koneksa-health/
Related People
Chris BenkoFounder
United States -
New York, New York
NA
LinkedIn
https://www.linkedin.com/in/cbenko/
Cambrian Network | $5,900,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
Further AI | $5,000,000 | (Apr 3, 2025)
Actively AI | $22,500,000 | (Apr 3, 2025)
Ropes | $3,100,000 | (Apr 3, 2025)